VANCOUVER, BC, April 29, 2025 /CNW/ - Trading resumes in:

Company: CanadaBis Capital Inc.

TSX-Venture Symbol: CANB

All Issues: Yes

Resumption (ET): 8:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

CALGARY, AB, April 28, 2025 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "Stigma Grow") (TSXV: CANB) today announces that CanadaBis has terminated the Arrangement Agreement (as defined below) with Simply Solventless Concentrates Ltd. (TSXV:HASH) (OTC:SSCLCF)("SSC") effective immediately.

On March 11, 2025, CanadaBis entered into an Arrangement Agreement with SSC pursuant to which SSC was to acquire all of the issued and outstanding common shares of CanadaBis by way of a court approved plan of arrangement under the Business Corporations Act (Alberta) (the "Transaction").   

VANCOUVER, BC, April 28, 2025 /CNW/ - The following issues have been halted by CIRO

Company: CanadaBis Capital Inc.

TSX-Venture Symbol: CANB

All Issues: Yes

Reason: Pending News

Halt Time (ET): 3:46 PM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

CALGARY, AB, April 14, 2025 /CNW/ - CanadaBis Capital Inc. ("CanadaBis") (TSXV: CANB) is pleased to announce that it has closed the final tranche of the previously announced brokered private placement of 11% unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture (the "Financing"). Closing of this final tranche consisted of the issuance of 1,415 Debentures for aggregate gross proceeds of $1,415,000.  Over the two tranches, the total Financing raised aggregate gross proceeds of $4,035,000. Research Capital Corporation acted as the sole agent and sole bookrunner in connection with the Financing (the "Agent").

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

CALGARY, AB, April 2, 2025 /CNW/ - CanadaBis Capital Inc. ("CanadaBis") (TSXV: CANB) is pleased to announce that it has closed the first tranche of the previously announced brokered private placement of 11% unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture (the "Financing"). Closing of the first tranche consisted of the issuance of 2,620 Debentures for aggregate gross proceeds of $2,620,000.

CanadaBis Capital Reports Strong Q2 Financial Results with $9M in Gross Revenue and $434,158 Adjusted EBITDA

CALGARY AB, March 31, 2025 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or the "Company") (TSXV: CANN), a leading player in the cannabis sector, is pleased to announce its financial results for the second quarter of 2025, ending January 31, 2025.

For Q2 2025, the Company reported gross revenue of $9,000,000, a significant increase of approximately $2,000,000 compared to the same period in the previous year. This represents strong year-over-year growth in line with CanadaBis's ongoing efforts to scale operations and optimize its portfolio of assets in the expanding cannabis market.

/Not for distribution to U.S. news wire services or for dissemination in the United States./

CALGARY, AB, March 27, 2025 /CNW/ - CanadaBis Capital Inc. ("CanadaBis") (TSXV: CANB) is pleased to announce that, due to strong investor demand, the brokered private placement previously announced on March 12, 2025 (the "March 12 Release") has been increased to up to 4,500 unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture, for gross proceeds of up to $4.5 million (the "Financing"). Research Capital Corporation is acting as the sole agent and sole bookrunner (the "Agent").

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

CALGARY, AB, March 12, 2025 /CNW/ - Simply Solventless Concentrates Ltd. (TSXV: HASH) (OTC: SSCLCF) ("SSC") and CanadaBis Capital Inc. ("CanadaBis" or "Stigma Grow") (TSXV: CANB) are pleased to announce that they have entered into an arrangement agreement (the "Arrangement Agreement") dated March 11, 2025 pursuant to which SSC will acquire all of the issued and outstanding common shares of CanadaBis by way of a court approved plan of arrangement under the Business Corporations Act (Alberta) (the "Transaction"). Upon closing of the Transaction, the combined entity is estimated to rank second and fifth in the Canadian concentrates and preroll categories respectively, excluding Quebec. CanadaBis also announces that it has launched a brokered private placement financing of up to 2,500 unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture, for gross proceeds of up to $2.5 million (the "Financing"), led by Research Capital as the sole agent and sole bookrunner.

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

CALGARY, AB, March 12, 2025 /CNW/ - Simply Solventless Concentrates Ltd. (TSXV: HASH) (OTC: SSCLCF) ("SSC") and CanadaBis Capital Inc. ("CanadaBis" or "Stigma Grow") (TSXV: CANB) are pleased to announce that they have entered into an arrangement agreement (the "Arrangement Agreement") dated March 11, 2025 pursuant to which SSC will acquire all of the issued and outstanding common shares of CanadaBis by way of a court approved plan of arrangement under the Business Corporations Act (Alberta) (the "Transaction"). Upon closing of the Transaction, the combined entity is estimated to rank second and fifth in the Canadian concentrates and preroll categories respectively, excluding Quebec. CanadaBis also announces that it has launched a brokered private placement financing of up to 2,500 unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture, for gross proceeds of up to $2.5 million (the "Financing"), led by Research Capital as the sole agent and sole bookrunner.

CALGARY, AB, Jan. 21, 2025 /CNW/ - CanadaBis Capital (CANB.V) a leader in the Canadian cannabis industry, is proud to announce the appointment of Mr. Shane Chana as Chief Financial Officer.

As CanadaBis continues to evolve and push forward, we are pleased to report that Shane Chana, CPA, CA has been appointed as Interim Chief Financial Officer. Mr. Chana was elected a director of CanadaBis in January 2020 and has previously served as the Chief Financial Officer of CanadaBis from December 2022 to August 2023.